BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18280771)

  • 1. Endoplasmic reticulum-associated degradation of mutant CFTR requires a guanine nucleotide-sensitive step.
    De Keukeleire B; Micoud J; Biard J; Benharouga M
    Int J Biochem Cell Biol; 2008; 40(9):1729-42. PubMed ID: 18280771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Traffic-independent function of the Sar1p/COPII machinery in proteasomal sorting of the cystic fibrosis transmembrane conductance regulator.
    Fu L; Sztul E
    J Cell Biol; 2003 Jan; 160(2):157-63. PubMed ID: 12538638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Base treatment corrects defects due to misfolding of mutant cystic fibrosis transmembrane conductance regulator.
    Namkung W; Kim KH; Lee MG
    Gastroenterology; 2005 Dec; 129(6):1979-90. PubMed ID: 16344066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncoupling proteasome peptidase and ATPase activities results in cytosolic release of an ER polytopic protein.
    Oberdorf J; Carlson EJ; Skach WR
    J Cell Sci; 2006 Jan; 119(Pt 2):303-13. PubMed ID: 16390870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correctors promote folding of the CFTR in the endoplasmic reticulum.
    Loo TW; Bartlett MC; Clarke DM
    Biochem J; 2008 Jul; 413(1):29-36. PubMed ID: 18361776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reticulocyte lysate as a model system to study endoplasmic reticulum membrane protein degradation.
    Carlson E; Bays N; David L; Skach WR
    Methods Mol Biol; 2005; 301():185-205. PubMed ID: 15917633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Misfolded BiP is degraded by a proteasome-independent endoplasmic-reticulum-associated degradation pathway.
    Donoso G; Herzog V; Schmitz A
    Biochem J; 2005 May; 387(Pt 3):897-903. PubMed ID: 15610068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusional mobility of the cystic fibrosis transmembrane conductance regulator mutant, delta F508-CFTR, in the endoplasmic reticulum measured by photobleaching of GFP-CFTR chimeras.
    Haggie PM; Stanton BA; Verkman AS
    J Biol Chem; 2002 May; 277(19):16419-25. PubMed ID: 11877404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintaining low Ca2+ level in the endoplasmic reticulum restores abnormal endogenous F508del-CFTR trafficking in airway epithelial cells.
    Norez C; Antigny F; Becq F; Vandebrouck C
    Traffic; 2006 May; 7(5):562-73. PubMed ID: 16643279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The forced aggresome formation of a bovine anion exchanger 1 (AE1) mutant through association with δF508-cystic fibrosis transmembrane conductance regulator upon proteasome inhibition in HEK293 cells.
    Adachi H; Kurooka T; Otsu W; Inaba M
    Jpn J Vet Res; 2010 Aug; 58(2):101-10. PubMed ID: 20715420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved maturation of CFTR by an ER export signal.
    Wendeler MW; Nufer O; Hauri HP
    FASEB J; 2007 Aug; 21(10):2352-8. PubMed ID: 17392477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Misassembled mutant DeltaF508 CFTR in the distal secretory pathway alters cellular lipid trafficking.
    Gentzsch M; Choudhury A; Chang XB; Pagano RE; Riordan JR
    J Cell Sci; 2007 Feb; 120(Pt 3):447-55. PubMed ID: 17213331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S-nitrosylating agents: a novel class of compounds that increase cystic fibrosis transmembrane conductance regulator expression and maturation in epithelial cells.
    Zaman K; Carraro S; Doherty J; Henderson EM; Lendermon E; Liu L; Verghese G; Zigler M; Ross M; Park E; Palmer LA; Doctor A; Stamler JS; Gaston B
    Mol Pharmacol; 2006 Oct; 70(4):1435-42. PubMed ID: 16857740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional rescue of DeltaF508-CFTR by peptides designed to mimic sorting motifs.
    Kim Chiaw P; Huan LJ; Gagnon S; Ly D; Sweezey N; Rotin D; Deber CM; Bear CE
    Chem Biol; 2009 May; 16(5):520-30. PubMed ID: 19477416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteasome-dependent pharmacological rescue of cystic fibrosis transmembrane conductance regulator revealed by mutation of glycine 622.
    Norez C; Bilan F; Kitzis A; Mettey Y; Becq F
    J Pharmacol Exp Ther; 2008 Apr; 325(1):89-99. PubMed ID: 18230692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanism underlying cystic fibrosis transmembrane conductance regulator transport from the endoplasmic reticulum to the proteasome includes Sec61beta and a cytosolic, deglycosylated intermediary.
    Bebök Z; Mazzochi C; King SA; Hong JS; Sorscher EJ
    J Biol Chem; 1998 Nov; 273(45):29873-8. PubMed ID: 9792704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin enhances cystic fibrosis transmembrane regulator expression by down-regulating calreticulin.
    Harada K; Okiyoneda T; Hashimoto Y; Oyokawa K; Nakamura K; Suico MA; Shuto T; Kai H
    Biochem Biophys Res Commun; 2007 Feb; 353(2):351-6. PubMed ID: 17178109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbohydrates act as sorting determinants in ER-associated degradation of tyrosinase.
    Svedine S; Wang T; Halaban R; Hebert DN
    J Cell Sci; 2004 Jun; 117(Pt 14):2937-49. PubMed ID: 15161941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AAV exploits subcellular stress associated with inflammation, endoplasmic reticulum expansion, and misfolded proteins in models of cystic fibrosis.
    Johnson JS; Gentzsch M; Zhang L; Ribeiro CM; Kantor B; Kafri T; Pickles RJ; Samulski RJ
    PLoS Pathog; 2011 May; 7(5):e1002053. PubMed ID: 21625534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CFTR: new members join the fold.
    Skach WR
    Cell; 2006 Nov; 127(4):673-5. PubMed ID: 17110327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.